DrugPatentWatch Database Preview

Details for Patent: 8,371,292

« Back to Dashboard

Which drugs does patent 8,371,292 protect, and when does it expire?

Patent 8,371,292 protects ALVESCO, ZETONNA, and OMNARIS, and is included in three NDAs.

This patent has ten patent family members in eleven countries.

Summary for Patent: 8,371,292

Title:	Use of ciclesonide for the treatment of respiratory diseases
Abstract:	The invention relates to new method of treatment of respiratory diseases, in particular the treatment of asthmatic children.
Inventor(s):	Bethke; Thomas (Constance, DE), Engelstaetter; Renate (Allensbach, DE), Wurst; Wilhelm (Constance, DE)
Assignee:	Nycomed GmbH (Constance, DE)
Application Number:	10/571,311
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form; Delivery;

Drugs Protected by US Patent 8,371,292

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Astrazeneca Pharms	ALVESCO	ciclesonide	AEROSOL, METERED;INHALATION	021658-002	Jan 10, 2008		RX	Yes	Yes						MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A RESPIRATORY DISEASE IN A CHILD
Astrazeneca Pharms	ALVESCO	ciclesonide	AEROSOL, METERED;INHALATION	021658-003	Jan 10, 2008		RX	Yes	Yes						MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A RESPIRATORY DISEASE IN A CHILD
Astrazeneca Pharms	ZETONNA	ciclesonide	AEROSOL, METERED;NASAL	202129-001	Jan 20, 2012		RX	Yes	Yes						TREATMENT OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHODS FOR TREATING A RESPIRATORY DISEASE IN A CHILD
Astrazeneca Pharms	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006		RX	Yes	Yes						TREATMENT OF NASAL SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER. TREATMENT OF NASAL SYMPTOMS ASSOCIATED W PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER

Foreign Priority and PCT Information for Patent: 8,371,292

PCT Information
PCT Filed	September 15, 2004	PCT Application Number:	PCT/EP2004/052172
PCT Publication Date:	March 24, 2005	PCT Publication Number:	WO2005/025578

International Family Members for US Patent 8,371,292

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Portugal	1670482
Japan	2012197306
Japan	5618452
Japan	2007505829